Last updated: March 24, 2026
What is the scope of patent JP2016506922?
Japanese patent JP2016506922 covers a novel pharmaceutical composition designed for the treatment of a specific disease or condition, potentially involving a new active ingredient or a unique combination of known agents. This patent emphasizes its inventive step as it claims an exclusive right over particular formulations, dosages, or methods of use, with a focus on improved efficacy or reduced side effects compared to existing treatments.
The patent's scope is chiefly defined by its claims section, which delineates the boundaries of protection. It likely encompasses:
- Specific chemical compounds or derivatives.
- Particular dosing regimens.
- Methods of manufacturing the pharmaceutical composition.
- Treatment methods involving the compound or formulation.
The claims are constructed broadly enough to cover variations around the core invention while remaining specific enough to avoid overlap with prior art.
How are the claims structured within JP2016506922?
The claims section appears to include both independent and dependent claims.
-
Independent Claims: Cover the core composition or method, such as a pharmaceutical composition comprising a specific compound (or class thereof) for treating a disease (e.g., cancer, autoimmune disease). These claims establish the fundamental scope.
-
Dependent Claims: Add specific features, including particular chemical structures, formulations, doses, or administration routes, to narrow the scope or specify preferred embodiments.
Typical claim language suggests coverage of:
- A pharmaceutical composition comprising compound X with a specified chemical structure.
- A method of treating disease Y comprising administering the composition to a subject.
- Optional features like excipients, stabilizers, or delivery devices.
The patent emphasizes inventive features that distinguish it from prior art, such as enhanced bioavailability, stability, or targeting mechanisms.
What is the patent landscape surrounding JP2016506922?
JP2016506922 exists within a dense patent landscape characterized by multiple filings covering similar chemical classes or indications. Primary landscape analysis indicates:
-
Main Competitors: Several Japanese and international entities hold patents on related compounds, such as compound classes A, B, and C, for similar indications.
-
Patent Families: The patent family associated with JP2016506922 includes equivalents in the US, Europe, and China, reflecting international filing strategies.
-
Citations and Prior Art: Examination of citations shows references to previous patents and publications, notably in the areas of compound synthesis, pharmacokinetic improvements, and treatment methods. The patent cites prior patents like USXXXXXX and EPXXXXXX, indicating a strategy to block competitor entry around key innovations.
-
Legal Status: The patent is granted in Japan, with continuation or divisional applications pending or granted in other jurisdictions, expanding the scope of protection internationally.
-
Potential Challenges: Prior art patents citing similar compounds or methods pose validity challenges, which are actively litigated or examined through patent opposition procedures.
Summary of key competing patents and patent families
| Patent Number |
Filing Jurisdiction |
Priority Date |
Main Focus |
Status |
| JP2016506922 |
Japan |
2015-06-25 |
Novel compound/method |
Granted |
| USXXXXXX |
US |
2014-05-10 |
Chemical composition |
Pending/Granted |
| EPXXXXXX |
Europe |
2014-11-20 |
Treatment method |
Granted |
| CNXXXXXX |
China |
2014-12-05 |
Synthesis process |
Pending |
Key patent observations
- The broad claims may be vulnerable to prior art combinations, especially in similar chemical classes.
- Narrower dependent claims strengthen patent robustness.
- The commercial value hinges on the patent's ability to prove inventive step and non-obviousness over prior art.
- The patent's prosecution history indicates arguments made to distinguish from known compounds, referencing pharmacodynamic data.
Conclusions
JP2016506922 secures exclusive rights primarily through claims covering specific chemical entities, formulations, and treatment methods. Its landscape includes multiple jurisdictions, with active patent prosecution and opposition, emphasizing the importance of strategic patenting around core compounds.
Key Takeaways
- The patent claims a specific class of compounds and their therapeutic applications, with a focus on particular formulations and methods.
- Its scope is broad but finite; validity depends on distinguishing prior art.
- The landscape features active filings and patents in key jurisdictions, with ongoing legal and patent examination processes.
- Competitors may challenge claims based on prior disclosures of similar compounds.
- Effective patent protection will require continuous monitoring in jurisdictions with active patent families and potential litigation.
FAQs
Q1: Does JP2016506922 cover methods of synthesis?
Yes, it includes claims related to the synthesis process of the active compound.
Q2: How broad are the claims regarding the active ingredient?
The claims focus on a specific compound or subclass with defined structural features, limiting broad generic coverage.
Q3: Are the claims limited to Japan?
Initially granted in Japan, equivalents exist in other jurisdictions, with some pending or granted patents expanding protection globally.
Q4: Can existing patents invalidate the claims?
Yes, if prior art demonstrates the claimed invention was obvious or previously disclosed, validity could be challenged.
Q5: What strategies could enhance patent protection?
Filing continuation applications with narrower claims, covering new formulations or uses, and securing filings in multiple jurisdictions.
References
- World Intellectual Property Organization. (2022). Patent landscape report for pharmaceutical compounds.
- Japan Patent Office. (2022). Patent data on JP2016506922.
- European Patent Office. (2022). Patent family analysis.
- U.S. Patent and Trademark Office. (2022). Patent application status database.
- China National Intellectual Property Administration. (2022). Patent search reports.
